Holen Sie sich die Stockscreener-App
1.56
9.83%
-0.17
Handel nachbörslich:
1.62
0.06
+3.85%
Schlusskurs vom Vortag:
$1.73
Offen:
$1.7
24-Stunden-Volumen:
54,638
Relative Volume:
0.76
Marktkapitalisierung:
$11.48M
Einnahmen:
$598.00K
Nettoeinkommen (Verlust:
$-44.93M
KGV:
-0.1877
EPS:
-8.31
Netto-Cashflow:
$-17.32M
1W Leistung:
-20.00%
1M Leistung:
-14.29%
6M Leistung:
-72.52%
1J Leistung:
-93.95%
1-Tages-Spanne:
$1.525
$1.70
1-Wochen-Bereich:
$1.525
$2.0399
52-Wochen-Spanne:
$1.525
$29.25
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Firmenname
Ernexa Therapeutics Inc
Sektor
Branche
Telefon
(617) 798-6700
Adresse
1035 CAMBRIDGE STREET, CAMBRIDGE
Vergleichen Sie ERNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.56 | 12.73M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc Aktie (ERNA) Neueste Nachrichten
Why Ernexa Therapeutics Inc. stock attracts strong analyst attentionDay Trading Setup Forecast with Trend Model - Newser
What to expect from Ernexa Therapeutics Inc. in the next 30 daysSwing Gain Strategy with Entry Forecast - Newser
Published on: 2025-08-01 20:26:13 - Newser
Why Ernexa Therapeutics Inc. stock is on top investor watchlistsFree AI Driven Stock Trend Forecast - Newser
Predicting Ernexa Therapeutics Inc. trend using moving averagesTrend Confirmation Scanner with Entry Focus - Newser
What MACD signals say about Ernexa Therapeutics Inc.Free Chart Alert System With Entry Targets - Newser
Is Ernexa Therapeutics Inc. a candidate for recovery playAI Trading Forecast Based on Big Data - Newser
Will Ernexa Therapeutics Inc. stock benefit from AI tech trendsDownside Control Plan With Support Analysis - Newser
Is Ernexa Therapeutics Inc. Forming a Bottom PatternTrade Insight With Community Collaboration Supported - metal.it
Using data models to predict Ernexa Therapeutics Inc. stock movementDaily Technical Chart Pattern Analysis Report - Newser
What are the technical indicators suggesting about Ernexa Therapeutics Inc.Best Dividend Guidance For Fast Growth - jammulinksnews.com
Published on: 2025-07-29 02:58:28 - Newser
How Ernexa Therapeutics Inc. stock performs during market volatilityPortfolio Safety Metrics and Return Analysis - Newser
What are the latest earnings results for Ernexa Therapeutics Inc.Expert Picks Tips With High Returns - jammulinksnews.com
What is Ernexa Therapeutics Inc. company’s growth strategyChart Pattern Data Feed For Beginners - jammulinksnews.com
What makes Ernexa Therapeutics Inc. stock price move sharplyHigh-octane financial growth - jammulinksnews.com
What are analysts’ price targets for Ernexa Therapeutics Inc. in the next 12 monthsHigh-yield investments - jammulinksnews.com
What is the dividend policy of Ernexa Therapeutics Inc. stockInvest confidently with professional market insights - jammulinksnews.com
How strong is Ernexa Therapeutics Inc. company’s balance sheetAchieve consistent profits with disciplined trading - jammulinksnews.com
Published on: 2025-07-27 21:08:51 - metal.it
What analysts say about Ernexa Therapeutics Inc. stockConsistently superior profits - PrintWeekIndia
Ernexa Therapeutics Inc. Stock Analysis and ForecastPhenomenal trading returns - PrintWeekIndia
How Ernexa Therapeutics Inc. stock reacts to Fed policy changesTremendous growth potential - jammulinksnews.com
Is Ernexa Therapeutics Inc. a good long term investmentBreakout portfolio performance - PrintWeekIndia
What drives Ernexa Therapeutics Inc. stock priceHigh-octane investment gains - jammulinksnews.com
Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):